How to Self-Inject Lovenox® is a video.
It is possible that you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis.If you do, your risk may be increased.
It is possible that you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis.If you do, your risk may be increased.
The steps of proper administration and disposal are outlined in this video.The steps are the same whether you use Lovenox or Enoxaparin.Refer back to this video whenever necessary after following the instructions carefully.
This is a step-by-step guide for self-injection.If you want to learn how to inject, print it off and keep it in a handy place.
In patients undergoing abdominal surgery, hip- or knee-replacement surgery or in acutely ill medical patients with severely restricted mobility, Lovenox can help reduce the risk of developing deep vein thrombosis.
A blood clot in or around the spine, which can result in long-term paralysis, can be caused by the increased risk of receiving epidural or spinal anesthesia, and taking Lovenox.If you do, your risk may be increased.
Take aspirin or blood thinners, and have an indwelling epidural catheter if you have a history of spine trauma.
It is important to get in touch with your doctor if you experience any of the symptoms.
Important Safety Information for Lovenox is shown at the end of the video.There is a Boxed Warning at Lovenox.com.
Hi, I'm here.You have just been prescribed an authorized generic.Lovenox helps to prevent a DVT blood clot, also called deep vein thrombosis, as you have already discussed with your healthcare professional.
If a clot breaks free and travels to your lungs, it could be fatal.
If you have certain health conditions or have just been hospitalized, your risk is higher.
It is important to continue these injections on your own.If you already know how to self-inject by your healthcare professional, this video may be a good reference.The purpose of the video is to help you understand how to inject.The steps are the same whether you are using Lovenox or the authorized generic.Let me introduce you to Amy, a person like you who is also using Lovenox.
I'm Amy.I will show you how to inject Lovenox the same way my healthcare professional showed me.I will walk you through the steps you need to know.
Inform your doctors and dentists about all of the medications you are taking, including those without a prescription.Before any surgery or any new drug is taken, be sure to tell your healthcare professionals you are taking Lovenox.
If you have questions or concerns, you can always call your healthcare professional.When you pick up your prescription, you can also talk to your pharmacist.
The process for injecting is the same, even though your packaging and syringe may not look like mine.
If you don't feel comfortable injecting Lovenox yourself, you can have a family member or a caregivers do it, just make sure they've been shown how by a healthcare professional.
For the exact number of days your healthcare professional prescribed Lovenox, make sure you inject it exactly.Don't skip any doses, and take each dose at the same time every day.
Let's get started.Make sure you wash your hands and find a place where you can lie down and see your stomach.
Next, look for a spot on the left or right side of your body that is at least two inches away from your belly button.
Don't inject into any scarred or bruised tissue, and make sure to alternate sides with each injection.
Clean the spot where you are going to inject.It's a good idea to let it dry completely.
The cap needs to be removed from the needle.To avoid bending the needle, pull it straight off.The needle is small and thin and big enough to reach the tissue underneath the skin.To make sure the needle stays clean, be careful not to set it down or let it touch anything.
There is a small bubble inside.If your healthcare professional tells you to adjust your dose, don't expel the air bubble.The injection is safe even with the air bubble.
If your healthcare professional has prescribed less than a full syringe, you should point the needle down and keep an eye on the numbers to make sure the dose is the same.
Place the needle in your hand and hold it like a pencil.You can make a fold in your skin by pinching an inch of the cleaned area on your abdomen.The full length of the needle should be inserted into the fold at a 90-degree angle.
Use your thumb to press the plunger down.It is important to keep pinching that fold of skin until the injection is done so that the medication doesn't enter any muscles.
When the needle is empty, pull it out and let go of your skin.The needle cap should not be put back on the needle after the injection.
Keeping your finger on the rod, point the needle away from you and anyone else around you.Push down on the rod until you hear a click.
Never reuse or throw away used needles, and never put the sharps container into the regular garbage.
If you notice any of the following, you should immediately call your doctor.Don't stop taking Lovenox without talking to the doctor who prescribed it.You should always consult with your doctor or healthcare professional if you have questions about your health.
If you have a question, talk to your healthcare professional or call the Lovenox Patient Support Line.Don't forget to watch to learn more Important Safety Information for Lovenox.
A blood clot in or around the spine, which can result in long-term paralysis, can be caused by the increased risk of receiving epidural or spinal anesthesia, and taking Lovenox.If you do, your risk may be increased.
It is important to get in touch with your doctor if you experience any of the symptoms.
If you have a low count of blood cells called platelets, Lovenox should not be used in you."thrombocytopenia" is a condition.Lovenox should not be used in patients who are allergic or sensitive to pork products.
Problems with clotting, high blood pressure, a recent ulcer, impaired vision due to diabetes, and excessive bleeding must be treated with Lovenox.Women with artificial heart valves are more likely to have blood clot.Patients who are treated with Lovenox must be monitored by their doctor.
A condition called "thrombocytopenia" can cause some patients on Lovenox to have drops in their platelet counts.There is a rare condition called "heparin-induced thrombocytopenia" that can occur with Lovenox.You must notify your healthcare professional if you have had this condition.
The blood's ability to clot is altered by Lovenox.There has been excessive bleeding with Lovenox.Bleeding can happen at any site with Lovenox use.The risk of excessive bleeding may be increased by the use of aspirin and other NSAID.You should tell your doctors and dentists about all of the medications you are taking, including those without a prescription.Before any surgery or any new drug is taken, be sure to tell your doctor or dentist that you are taking Lovenox.
Patients should be monitored by their doctor while taking Lovenox.If you are on Lovenox, your doctor is likely to order blood tests to measure your blood count and check for signs of bleeding.
If you notice any of the following, you should immediately call your doctor.
Local irritation, pain, bruised, or redness of the skin at the site of injection are the most common side effects of Lovenox.There are other common side effects.
You should always consult with your doctor or healthcare professional if you have questions about your health.
In patients undergoing abdominal surgery, hip- or knee-replacement surgery or in acutely ill medical patients with severely restricted mobility, Lovenox can help reduce the risk of developing DVT blood clot.
For additional important information, please see Full Prescribing Information.
Epidural or spinal hematomas can occur in patients who are receiving neuraxial anesthesia or undergoing a spinal puncture.Long-term or permanent paralysis may result from these hematomas.
The information on this website and database is not reviewed by the US.The terms, limitations and conditions set by the website and/or database producer apply to the use of and access to this information.
There is a risk of SPINAL/EPIDURAL HEMATOMAS in patients who are receiving neuraxial anesthesia or undergoing a spinal puncture.Long-term or permanent paralysis may result from these hematomas.When scheduling patients for procedures, consider the risks.There are factors that can increase the risk of developing epidural or spine hematomas in these patients.Patients should be monitored for signs and symptoms of neurological impairment.Immediate treatment is necessary if neurological compromise is noted.Consider the benefits and risks of neuraxial intervention in patients who are anticoagulated.Lovenox can be used in patients with active major bleeding, a history of heparin-induced thrombocytopenia, or in the presence of circulating antibodies.Lovenox should be used with extreme caution in certain conditions.It is possible to have an analgesia or a spine puncture.While the exact timing is not known, the pharmacokinetic profile of Lovenox should be considered when determining the timing of placement/removal of an epidural catheter.There have been reports of major hemorrhages.Some of the cases have been fatal.Bleeding can happen anywhere during Lovenox therapy.A search for a bleeding site should result from an unexplained fall in hematocrit or blood pressure.Additional considerations are needed for patients with creatinine clearance.Obtain hemostasis at the puncture site before sheath removal and observe the site for signs of bleeding or hematoma formation.The rate of major hemorrhages (defined as requiring 5 or more units of blood for transfusion, or 15% drop in HCT or clinically overt bleeding, including intracranial hemorrhage [ICH]) at 30 days was 2% in the Lovenox group.The UFH group had a rate of 0.7% at 30 days.The Lovenox group had a lower rate of ICH than the UFH group.Lovenox should be used with caution in patients with bleeding diathesis or a history of recent gastrointestinal ulceration.It is possible that Lovenox may cause Heparin-Induced Thrombocytopenia.HITTS can cause organ infarction, limb ischemia or death.Keep an eye on thrombocytopenia of any degree.It is not advisable to use Lovenox in patients with a history ofHIT within the past 100 days or in the presence of circulating antibodies.For several years, circulating antibodies may persist.After a careful benefit-risk assessment and non-heparin alternative treatments are considered, the decision to use Lovenox in such a case must be made.Lovenox can cause thrombocytopenia.Any degree of clotytopenia should be monitored.Lovenox should be stopped if the platelet count falls below 100,000/mm3.Lovenox can't be used with other LMWH or UFH as they differ in their manufacturing process, anti-Xa activities, units, and dosages.There is a risk of valve thrombosis in pregnant women with mechanical heart valves.When pregnant, women with mechanical heart valves may be at higher risk for thromboembolism, as well as having a higher rate of fetal loss.Monitoring the levels of anti-Factor Xa may be necessary.There can be serious and fatal adverse reactions in neonates and low birth weight infants who are treated with benzyl alcohol–preserved drugs.Periodic complete blood counts, including platelet count, and stool occult blood tests are recommended during the course of treatment with Lovenox.The most common adverse reactions were bleeding, anemia, thrombocytopenia, elevation of the ecchymosis, nausea, and injection site pain.There are indications for the prophylactic of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing abdominal surgery who are at risk.Lovenox has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction and death in patients with acute ST-segment elevation MI.You can see full Prescribing Information.Call your local sanofi-aventis U.S. Representative for more information.Lovenox can be purchased in the pharmacy.Information on Sharps Medical Waste disposal can be found here.
Epidural or spinal hematomas can occur in patients who are anticoagulated with lowmolecular weight heparins or heparinoids.Long-term or permanent paralysis may result from these hematomas.When scheduling patients for procedures, consider the risks.There are factors that can increase the risk of developing an injury.
Patients should be monitored for signs and symptoms of neurological impairment.Immediate treatment is necessary if neurological compromise is noted.
Consider the benefits and risks of neuraxial intervention in patients who are anticoagulated.
Lovenox is indicated for the prevention of deep vein thrombosis.
When administered with aspirin, Lovenox is indicated for the protection of the cardiovascular system from the effects of unstable angina and non–Q-wave MI.
When administered with aspirin, Lovenox has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction or death in patients with acute ST-segment elevation MI.
Call your local sanofi-aventis U.S. Representative for more information.
There is a risk of SPINAL/EPIDURAL HEMATOMAS in patients who are receiving neuraxial anesthesia or undergoing a spinal puncture.Long-term or permanent paralysis may result from these hematomas.When scheduling patients for procedures, consider the risks.There are factors that can increase the risk of developing epidural or spine hematomas in these patients.Patients should be monitored for signs and symptoms of neurological impairment.Immediate treatment is necessary if neurological compromise is noted.Consider the benefits and risks of neuraxial intervention in patients who are anticoagulated.Lovenox can be used in patients with active major bleeding, a history of heparin-induced thrombocytopenia, or in the presence of circulating antibodies.Lovenox should be used with extreme caution in certain conditions.It is possible to have an analgesia or a spine puncture.While the exact timing is not known, the pharmacokinetic profile of Lovenox should be considered when determining the timing of placement/removal of an epidural catheter.There have been reports of major hemorrhages.Some of the cases have been fatal.Bleeding can happen anywhere during Lovenox therapy.A search for a bleeding site should result from an unexplained fall in hematocrit or blood pressure.Additional considerations are needed for patients with creatinine clearance.Obtain hemostasis at the puncture site before sheath removal and observe the site for signs of bleeding or hematoma formation.The rate of major hemorrhages (defined as requiring 5 or more units of blood for transfusion, or 15% drop in HCT or clinically overt bleeding, including intracranial hemorrhage [ICH]) at 30 days was 2% in the Lovenox group.The UFH group had a rate of 0.7% at 30 days.The Lovenox group had a lower rate of ICH than the UFH group.Lovenox should be used with caution in patients with bleeding diathesis or a history of recent gastrointestinal ulceration.It is possible that Lovenox may cause Heparin-Induced Thrombocytopenia.HITTS can cause organ infarction, limb ischemia or death.Keep an eye on thrombocytopenia of any degree.It is not advisable to use Lovenox in patients with a history ofHIT within the past 100 days or in the presence of circulating antibodies.For several years, circulating antibodies may persist.After a careful benefit-risk assessment and non-heparin alternative treatments are considered, the decision to use Lovenox in such a case must be made.Lovenox can cause thrombocytopenia.Any degree of clotytopenia should be monitored.Lovenox should be stopped if the platelet count falls below 100,000/mm3.Lovenox can't be used with other LMWH or UFH as they differ in their manufacturing process, anti-Xa activities, units, and dosages.There is a risk of valve thrombosis in pregnant women with mechanical heart valves.When pregnant, women with mechanical heart valves may be at higher risk for thromboembolism, as well as having a higher rate of fetal loss.Monitoring the levels of anti-Factor Xa may be necessary.There can be serious and fatal adverse reactions in neonates and low birth weight infants who are treated with benzyl alcohol–preserved drugs.Periodic complete blood counts, including platelet count, and stool occult blood tests are recommended during the course of treatment with Lovenox.The most common adverse reactions were bleeding, anemia, thrombocytopenia, elevation of the ecchymosis, nausea, and injection site pain.There are indications for the prophylactic of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing abdominal surgery who are at risk.Lovenox has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction and death in patients with acute ST-segment elevation MI.You can see full Prescribing Information.Call your local sanofi-aventis U.S. Representative for more information.Lovenox can be purchased in the pharmacy.Information on Sharps Medical Waste disposal can be found here.
Epidural or spinal hematomas can occur in patients who are anticoagulated with lowmolecular weight heparins or heparinoids.Long-term or permanent paralysis may result from these hematomas.When scheduling patients for procedures, consider the risks.There are factors that can increase the risk of developing an injury.
Patients should be monitored for signs and symptoms of neurological impairment.Immediate treatment is necessary if neurological compromise is noted.
Consider the benefits and risks of neuraxial intervention in patients who are anticoagulated.
Lovenox is indicated for the prevention of deep vein thrombosis.
When administered with aspirin, Lovenox is indicated for the protection of the cardiovascular system from the effects of unstable angina and non–Q-wave MI.
When administered with aspirin, Lovenox has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction or death in patients with acute ST-segment elevation MI.